Home › Interstitial Lung Diseases › Ohio › Columbus
Interstitial Lung Diseases clinical trials in Columbus, OH
5 studies for Interstitial Lung Diseases are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Ohio State Richard M. Ross Heart Hospital, Columbus
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- The Ohio State University, Columbus
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RecruitingPhase 2
- Ohio State University, Columbus
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
RecruitingPhase 3
- The Ohio State University Wexner Medical CEnter, Columbus
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
RecruitingPhase 1Healthy volunteers welcome
- GSK Investigational Site, Columbus
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY19 studies
- Philadelphia, PA17 studies
- Los Angeles, CA15 studies
- Kansas City, KS14 studies
- Durham, NC13 studies
- Chicago, IL13 studies
- Charleston, SC13 studies
- Houston, TX13 studies
- Ann Arbor, MI11 studies
- Aurora, CO11 studies
- Rochester, MN10 studies
- Birmingham, AL10 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer54 studies
- Cancer (all types)39 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer26 studies
- Endometrial Cancer26 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
- Colorectal Cancer23 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.